相似文献
1
Editorial Comment: Over, Under, or Just Right? How do we interpret ICD utilization in the modern era?
Indian Pacing Electrophysiol J. 2015 Apr 1;15(1):15-9. doi: 10.1016/s0972-6292(16)30837-3. eCollection 2015 Jan-Feb.
2
Right Ventricular Dysfunction and the Effect of Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure.
Circ Arrhythm Electrophysiol. 2019 Mar;12(3):e007022. doi: 10.1161/CIRCEP.118.007022.
3
Primary prevention of sudden cardiac death by implantable cardioverter-defibrillator therapy in Chinese patients with heart failure: a single-center experience.
Chin Med J (Engl). 2010 Apr 5;123(7):848-51.
4
Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?
JACC Clin Electrophysiol. 2017 Mar;3(3):291-298. doi: 10.1016/j.jacep.2016.09.006.
5
Cost-effectiveness of primary implanted cardioverter defibrillator for sudden death prevention in congestive heart failure.
Cardiovasc Drugs Ther. 2004 Mar;18(2):161-70. doi: 10.1023/B:CARD.0000029034.65769.f7.
6
Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey.
Europace. 2017 Apr 1;19(4):660-664. doi: 10.1093/europace/eux089.
7
Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
Expert Rev Cardiovasc Ther. 2009 Feb;7(2):181-95. doi: 10.1586/14779072.7.2.181.
8
[Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].
Ann Cardiol Angeiol (Paris). 2015 Feb;64(1):27-31. doi: 10.1016/j.ancard.2014.08.018. Epub 2014 Sep 18.
9
Michel Mirowski and the beginning of a new era of fighting sudden arrhythmic death.
Herzschrittmacherther Elektrophysiol. 2015 Jun;26(2):61-9. doi: 10.1007/s00399-015-0374-6. Epub 2015 Jun 10.
10
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Eur Heart J. 2000 Dec;21(24):2071-8. doi: 10.1053/euhj.2000.2476.
本文引用的文献
1
Future Developments in Nonsurgical Epicardial Therapies.
Card Electrophysiol Clin. 2010 Mar;2(1):135-146. doi: 10.1016/j.ccep.2009.11.014.
2
Under-Utilization of Implantable Cardioverter Defibrillators in Patients with Heart Failure - The Current State of Sudden Cardiac Death Prophylaxis.
Indian Pacing Electrophysiol J. 2015 Apr 1;15(1):20-9. doi: 10.1016/S0972-6292(16)30838-5. eCollection 2015 Jan-Feb.
3
A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure.
Eur Heart J. 2015 Feb 14;36(7):434-9. doi: 10.1093/eurheartj/ehu455.
4
Angiotensin-neprilysin inhibition versus enalapril in heart failure.
N Engl J Med. 2014 Sep 11;371(11):993-1004. doi: 10.1056/NEJMoa1409077. Epub 2014 Aug 30.
5
Long-term outcome of defibrillator recipients included in the federal audit conducted by the Department of Justice.
Am J Cardiol. 2014 Sep 1;114(5):723-6. doi: 10.1016/j.amjcard.2014.06.003. Epub 2014 Jun 18.
6
Appropriateness of primary prevention implantable cardioverter-defibrillators at the time of generator replacement: are indications still met?
J Am Coll Cardiol. 2014 Jun 10;63(22):2388-94. doi: 10.1016/j.jacc.2014.03.025. Epub 2014 Apr 9.
7
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association.
Circulation. 2014 Jan 21;129(3):399-410. doi: 10.1161/01.cir.0000442015.53336.12.
8
The disconnect between the guidelines, the appropriate use criteria, and reimbursement coverage decisions: the ultimate dilemma.
J Am Coll Cardiol. 2014;63(1):12-4. doi: 10.1016/j.jacc.2013.07.016. Epub 2013 Jul 31.
9
ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance.
Heart Rhythm. 2013 Apr;10(4):e11-58. doi: 10.1016/j.hrthm.2013.01.008. Epub 2013 Mar 7.
10
Use of a screening tool improves appropriate referral to an electrophysiologist for implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.
Circ Cardiovasc Qual Outcomes. 2011 Mar;4(2):152-6. doi: 10.1161/CIRCOUTCOMES.110.956987. Epub 2011 Feb 8.
Zotero 插件